Haloperidol

Product NDC
70518-2620
11-digit product format
705182620
Labeler code
70518
Product ID
70518-2620_e9457c2d-e37e-c66c-e053-2995a90a4c5e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Haloperidol
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA211061
Marketing category
ANDA
Marketing start
2020-03-10
Marketing end
0000-00-00
Substance
HALOPERIDOL
Active strength
5 mg/1
Pharmacologic classes
Typical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2620-02022-01-30C16284748780-1d6a99b39-9697-a426-e053-dadaa90af4c2331e5182-5342-4bd4-88c9-562bbd567130
70518-2620-02022-01-28C16284748780-1d6a99b39-9697-a426-e053-dadaa90af4c2331e5182-5342-4bd4-88c9-562bbd567130

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2620-07051826200030 TABLET in 1 BLISTER PACK (70518-2620-0) 30 tablet2020-03-100000-00-00NoNoCurrent